Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Gaelic, Athlone Complete First Phase of Post-Merger Integration
Tuesday, June 09, 2026
Gaelic Laboratories and Athlone Laboratories have completed the first phase of their post-merger integration, aligning key systems and capabilities ... read more
Fujifilm Announces Leadership Changes to Enhance Life Sciences Capabilities
Monday, June 08, 2026
FUJIFILM Holdings America Corporation announced additional leadership responsibilities for three key leaders in its Life Sciences Group companies. read more
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
Monday, June 08, 2026
WuXi Biologics announced that it has completed the topping out of the Drug Product (DP) facility at its Singapore CRDMO Hub. read more
Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies
Monday, June 08, 2026
Made Scientific and Pluristyx announced a strategic partnership to integrate Pluristyx Technology including GMP iPSC lines and derivative cell types, ... read more
Ardena Names Chief Scientific Officer
Monday, June 08, 2026
Ardena announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer. read more